Tranexamic acid versus ε-aminocaproic acid: Efficacy and safety in paediatric cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 6, 2011, Pages 892-897

  Martin, Klaus ^a   Breuer, Tamás ^a,b   Gertler, Ralph ^a   Hapfelmeier, Alexander ^c   Schreiber, Christian ^a   Lange, Rüdiger ^a   Hess, John ^a   Wiesner, Gunther ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aminocaproic acid; Blood loss; Outcome; Paediatric cardiac surgery; Tranexamic acid

Indexed keywords

AMINOCAPROIC ACID; TRANEXAMIC ACID;

ANTIFIBRINOLYTIC THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CHILD; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORWARD HEART FAILURE; HEART SURGERY; HEMOSTASIS; HUMAN; INFANT; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NEWBORN; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REOPERATION; SEIZURE; THROMBOSIS;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COHORT STUDIES; DRUG EVALUATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; REOPERATION; SEIZURES; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 79955619126     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.09.041     Document Type: Article

References (23)

1. Mannucci P.M., Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007, 356:2301-2311.
2. Brown J.R., Birkmeyer N.J., O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007, 115:2801-2813.
3. Ferguson T.B. Aprotinin - are there lessons learned?. JAMA 2007, 297:527-529.
4. Mangano D.T., Miao Y., Vuylsteke A., Tudor I.C., Juneja R., Filipescu D., Hoeft A., Fontes M.L., Hillel Z., Ott E., Titov T., Dietzel C., Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007, 297:471-479.
5. Chauhan S., Das S.N., Bisoi A., Kale S., Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004, 18:141-143.
6. Eaton M.P. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008, 106:1087-1100.
7. Martin K., Wiesner G., Breuer T., Lange R., Tassani P. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008, 107:1783-1790.
8. Breuer T., Martin K., Wilhelm M., Wiesner G., Schreiber C., Hess J., Lange R., Tassani P. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009, 35:167-171. [author reply 171].
9. Frederiksen M.C., Bowsher D.J., Ruo T.I., Henthorn T.K., Ts'ao C.H., Green D., Atkinson A.J. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther 1984, 35:387-393.
10. Akcan-Arikan A., Zappitelli M., Loftis L.L., Washburn K.K., Jefferson L.S., Goldstein S.L. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007, 71:1028-1035.
11. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987, 34:571-590.
12. Jenkins K.J., Gauvreau K., Newburger J.W., Spray T.L., Moller J.H., Iezzoni L.I. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002, 123:110-118.
13. Henry D., Carless P., Fergusson D., Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009, 180:183-193.
14. Fergusson D.A., Hebert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., Teoh K., Duke P.C., Arellano R., Blajchman M.A., Bussieres J.S., Cote D., Karski J., Martineau R., Robblee J.A., Rodger M., Wells G., Clinch J., Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008, 358:2319-2331.
15. Schouten E.S., van de Pol A.C., Schouten A.N., Turner N.M., Jansen N.J., Bollen C.W. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 2009, 10:182-190.
16. Furtmuller R., Schlag M.G., Berger M., Hopf R., Huck S., Sieghart W., Redl H. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002, 301:168-173.
17. Szekely A., Sapi E., Breuer T., Kertai M.D., Bodor G., Vargha P., Szatmari A. Aprotinin and renal dysfunction after pediatric cardiac surgery. Paediatr Anaesth 2008, 18:151-159.
18. Dittrich S., Dahnert I., Vogel M., Stiller B., Haas N.A., Alexi-Meskishvili V., Lange P.E. Peritoneal dialysis after infant open heart surgery: observations in 27 patients. Ann Thorac Surg 1999, 68:160-163.
19. Guzzetta N.A., Evans F.M., Rosenberg E.S., Fazlollah T.M., Baker M.J., Wilson E.C., Kaiser A.M., Tosone S.R., Miller B.E. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Anesth Analg 2009, 108:448-455.
20. Werner H.A., Wensley D.F., Lirenman D.S., LeBlanc J.G. Peritoneal dialysis in children after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997, 113:64-68. [discussion 68-70].
21. Garwood S., Mathew J., Barash P.G., Hines R. Reduced blood loss at the expense of renal dysfunction: Is epsilon aminocaproic acid a blow to the kidney (abstract). Anesthesiology 1997, 87:A67.
22. Petaja J., Peltola K. Venous thrombosis in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1997, 11:889-894.
23. Levin E., Wu J., Devine D.V., Alexander J., Reichart C., Sett S., Seear M. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000, 83:54-59.